ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 345

The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study

Sandra Bourke1,2, Nicola Dalbeth1, William J. Taylor3, Anthony Doyle1 and Merryn Gott1, 1University of Auckland, Auckland, New Zealand, 2Auckland district health board, Auckland, New Zealand, 3University of Otago, Wellington, New Zealand

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Imaging, inflammatory arthritis and patient preferences, Musculoskeletal

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Musculoskeletal (MSK) imaging is widely used in rheumatology for diagnosis and management of arthritis. Although the technical and performance properties of MSK imaging tests are well recognised, few studies have examined the patient experience of undergoing these tests. The aim of this study was to understand the patient experience of MSK imaging tests for investigation of inflammatory arthritis, and factors that contribute to this experience.

Methods: In this mixed methods study, we conducted a thematic analysis of semi-structured interviews with 33 patients who had undergone a recent peripheral joint conventional radiograph, ultrasound, computed tomography or magnetic resonance imaging scan for investigation of inflammatory arthritis. Data from these interviews were used to generate an 18-item questionnaire about the experience of MSK imaging which was posted to rheumatology clinic patients within six weeks of peripheral joint imaging. Variables associated with the overall patient experience of the test were analysed using stepwise linear regression models.

Results: Analysis of the interviews identified six themes; knowledge about the test, the role of imaging in clinical care, awareness of potential harm, discomfort, experience of waiting, and ‘seeing is believing’. Patient understanding was informed by the information they received and previous experience of the test. Patients perceived imaging as part of clinical care and believed the benefits of having the test outweighed the potential risks. Discomfort was experienced by some patients, both emotional due to negative experiences of interactions with staff and claustrophobia, and physical due to positioning for the test. Some patients felt anxious about waiting times for the test and for receiving results. Viewing of the images (particularly during ultrasound) improved understanding of disease and gave a sense of personal involvement in their arthritis treatment. Completed questionnaires were available from 132 patients. In regression analysis (Table), a strong negative association was observed between the ‘Discomfort during the test’ item and the overall experience of the test (standardised beta 0.35, p<0.001). ‘Staff made the experience better’ (0.26, p<0.001) and ‘Information provided’ (0.28, p<0.001) were positively associated with the overall experience of the test. For those who viewed their images, ‘looking at the images with my doctor made me feel more involved in my care’ (0.24, p<0.019) was also associated positively with overall experience.

Conclusion: Factors before, during and after a musculoskeletal imaging test contribute to the patient experience. The overall experience is most influenced by patient discomfort, interactions with staff during the test, information provided, and viewing images to improve patient involvement in clinical care.

Table 1. Stepwise linear regression analysis of question items (excluding non-applicable questions) independently associated with overall experience of the test (all participants)

Dependent variable

Predictors

Standardized ß

R2 change

p

Model

Overall experience

Discomfort during the test

-0.35

0.16

<0.001

Adjusted R2 = 0.32

F = 20.0

P < 0.001

Information provided

0.28

0.11

<0.001

Staff made the experience better

0.26

0.06

<0.001

Items included in this analysis: imaging modality and all questionnaire items that did not include a not applicable response.


Disclosure: S. Bourke, None; N. Dalbeth, Takeda, AstraZeneca, Abbvie, 9; W. J. Taylor, Pfizer Inc, 5; A. Doyle, None; M. Gott, None.

To cite this abstract in AMA style:

Bourke S, Dalbeth N, Taylor WJ, Doyle A, Gott M. The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-patient-experience-of-musculoskeletal-imaging-tests-for-investigation-of-inflammatory-arthritis-a-mixed-methods-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-patient-experience-of-musculoskeletal-imaging-tests-for-investigation-of-inflammatory-arthritis-a-mixed-methods-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology